Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial
Titel:
Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial
Auteur:
Short, Nicholas J Kantarjian, Hagop M Loghavi, Sanam Huang, Xuelin Qiao, Wei Borthakur, Gautam Kadia, Tapan M Daver, Naval Ohanian, Maro Dinardo, Courtney D Estrov, Zeev Kanagal-Shamanna, Rashmi Maiti, Abhishek Benton, Christopher B Bose, Prithviraj Alvarado, Yesid Jabbour, Elias Kornblau, Steven M Pemmaraju, Naveen Jain, Nitin Gasior, Yvonne Richie, Mary Ann Pierce, Sherry Cortes, Jorge Konopleva, Marina Garcia-Manero, Guillermo Ravandi, Farhad